BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33952718)

  • 1. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients.
    Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z
    Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
    Luo X; Tang J; Xuan H; Liu J; Li X
    Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
    Chen W; Lin Y; Huang J; Yan Z; Cao H
    J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
    Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
    Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
    He M; Hu C; Deng J; Ji H; Tian W
    World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 12. The novel prognostic risk factor STC2 can regulate the occurrence and progression of osteosarcoma via the glycolytic pathway.
    Yu B; Zhang F; Liu L; Liang Y; Tang X; Peng Y; Cai F; Zeng D; Yuan X; Li J; Guo Y; Lv B; Wang M; Liao Q; Lv XB
    Biochem Biophys Res Commun; 2021 May; 554():25-32. PubMed ID: 33774276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
    Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
    BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
    Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
    Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
    Zhang L; Zhang Z; Yu Z
    J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
    Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
    Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.